FDA Inspection 1318878 — Northern Illinois Blood Bank, Inc
The FDA completed an inspection of Northern Illinois Blood Bank, Inc on May 19, 2026 in Rockford, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 19, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Rockford, IL (United States)